Skinvisible Inc (SKVI) financial statements (2022 and earlier)

Company profile

Business Address 6320 S SANDHILL ROAD
LAS VEGAS, NV 89120
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments663612233 
Cash and cash equivalents663612233 
Receivables0810827105
Inventory, net of allowances, customer advances and progress billings   17268091
Inventory   17268091
Other undisclosed current assets8751323911
Total current assets:745016423169497
Noncurrent Assets
Property, plant and equipment   0012
Intangible assets, net (including goodwill)153150165179206245302
Intangible assets, net (excluding goodwill)153150165179206245302
Other undisclosed noncurrent assets    110  
Total noncurrent assets:153150165179316246303
TOTAL ASSETS:227200182220632340401
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,040865597944613808529
Interest and dividends payable1,4751,0214921,1691,674760539
Other undisclosed accounts payable and accrued liabilities(435)(156)106(225)(1,062)48(10)
Debt      1,572
Due to related parties27524740177010
Other undisclosed current liabilities1,9941,8012,5453,9556,7625,5703,515
Total current liabilities:3,0612,7193,1894,9407,3926,4485,627
Noncurrent Liabilities
Long-term debt and lease obligation 220 1751,380  
Long-term debt, excluding current maturities 220 1751,380  
Other undisclosed noncurrent liabilities2,5821,716 (175)(1,380) 436
Total noncurrent liabilities:2,5821,936    436
Total liabilities:5,6434,6553,1894,9407,3926,4486,063
Stockholders' equity
Stockholders' equity attributable to parent, including:(5,416)(4,455)(3,007)(4,719)(6,760)(6,108)(5,662)
Common stock5543137124116
Additional paid in capital30,35330,24130,18224,77524,75123,64022,054
Accumulated other comprehensive loss    (31,709)(29,882) 
Accumulated deficit(35,773)(34,700)(33,253)(31,551)(31,709)(29,882)(27,831)
Other undisclosed stockholders' equity attributable to parent  602,05331,77129,892 
Total stockholders' equity:(5,416)(4,455)(3,007)(4,719)(6,760)(6,108)(5,662)
TOTAL LIABILITIES AND EQUITY:227200182220632340401

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues6631534369629109175
Revenue from related parties 123  
Other income  (15)(5)(5)00
Cost of revenue(3) (18)(21)(42)(37)(57)
Cost of goods and services sold  (10)    
Other undisclosed gross profit 123     
Gross profit:660276264958772118
Operating expenses(472)(529)(565)(647)(951)(914)(1,198)
Other operating expense, net
(Other Expenses)
(1,261)(1,194)(1,162)(756)(1,463)(1,209) 
Other undisclosed operating income1,2611,1941,1627561,4631,209 
Operating income (loss):188(254)(540)(598)(364)(842)(1,081)
Nonoperating income
(Debt Instrument, Convertible, Beneficial Conversion Feature)
  3,649 6711,374548
Interest and debt expense(1,103)(1,194)(999)(1,334)(1,555)(1,328)(911)
Income (loss) from continuing operations before equity method investments, income taxes:(915)(1,448)2,111(1,932)(1,248)(796)(1,444)
Income from equity method investments   2213  
Net income (loss):(915)(1,448)2,111(1,910)(1,235)(796)(1,444)
Other undisclosed net income (loss) attributable to parent(157) (3,813)2,068(591)(1,255)(547)
Net income (loss) available to common stockholders, diluted:(1,073)(1,448)(1,702)158(1,827)(2,051)(1,990)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(915)(1,448)2,111(1,910)(1,235)(796)(1,444)
Comprehensive income (loss), net of tax, attributable to parent:(915)(1,448)2,111(1,910)(1,235)(796)(1,444)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: